Clinical Trial Update: Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating paclitaxel, carboplatin, and cetuximab for non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cetuximab (Erbitux) (Cetuximab)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED